Vyndaqel (tafamidis meglumine) is a transthyretin stabilizer that may be given to reduce death or hospitalization caused by heart problems in adults with cardiomyopathy (damage of the heart muscle) caused by wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM).

VYNDAQEL and VYNDAMAX are prescription medicines used to treat adults with cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAQEL and VYNDAMAX are safe and effective in children. have liver problems.

Aug 14, 2024 · Overview: Vyndaqel is used to treat transthyretin amyloid cardiomyopathy (ATTR-CM). It helps to slow the damage to your heart muscle. There are no known side effects of Vyndaqel. Contact your...

VYNDAQEL and VYNDAMAX are indicated for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.

Tafamidis, sold under the brand names Vyndaqel and Vyndamax, [5] is a medication used to delay disease progression in adults with certain forms of transthyretin amyloidosis.

Dec 11, 2024 · Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) are prescription medications used for the treatment of cardiomyopathy caused by transthyretin amyloidosis (ATTR-CM).

The recommended dosage is either VYNDAQEL 80 mg (four 20-mg tafamidis meglumine capsules) orally once daily or VYNDAMAX 61 mg (one 61-mg tafamidis capsule) orally once daily.

Vyndaqel is indicated for the treatment of transthyretin amyloidosis in adult patients with stage-1 symptomatic polyneuropathy to delay peripheral neurologic impairment.

Feb 7, 2022 · Vyndaqel (tafamidis) is a medication taken by mouth used for a rare type of heart disease called transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM). It's available as two different brand names and is taken once per day.

May 19, 2020 · Vyndamax (tafamidis) and Vyndaqel (tafamidis meglumine) are prescription capsules used for cardiomyopathy. Learn about side effects, uses, dosage, and more.